Technetium Pentetate

CHEMBL2110551 Phase 4 승인됨 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

Technetium pentetate (99mTc-DTPA, diethylenetriaminepentaacetic acid) is a radiolabeled chelate that is exclusively filtered by the glomerulus without tubular secretion or reabsorption, making it suitable for measuring glomerular filtration rate (GFR) and performing renal perfusion and dynamic scintigraphy. It is also used for lung ventilation imaging when administered as an aerosol, and for brain imaging to detect disruption of the blood-brain barrier. Its versatility makes it one of the most widely used radiopharmaceuticals.

치료 영역

작용 기전

Contains a radioactive isotope that accumulates in specific tissues or organs, enabling detection and imaging of physiological processes or pathological conditions using nuclear medicine techniques.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

기전

Contains a radioactive isotope that accumulates in specific tissues or organs, enabling detection and imaging of physiological processes or pathological conditions using nuclear medicine techniques.

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

Technetium pentetate (99mTc-DTPA, diethylenetriaminepentaacetic acid) is a radiolabeled chelate that is exclusively filtered by the glomerulus without tubular secretion or reabsorption, making it suitable for measuring glomerular filtration rate (GFR) and performing renal perfusion and dynamic scintigraphy. It is also used for lung ventilation imaging when administered as an aerosol, and for brain imaging to detect disruption of the blood-brain barrier. Its versatility makes it one of the most widely used radiopharmaceuticals.

Contains a radioactive isotope that accumulates in specific tissues or organs, enabling detection and imaging of physiological processes or pathological conditions using nuclear medicine techniques.

Yes, Technetium Pentetate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2110551. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.